Renk shares continued their recovery on Monday, climbing 2.6% to €50.38, as the market absorbed the placement of a large block of stock by its biggest shareholder. The rally, which has pushed the defence driveline specialist’s equity up nearly 13% over the past week, was underpinned by the removal of a key overhang: KNDS placed 5.8 million shares — representing 5.80% of the capital — through an accelerated bookbuild handled by Deutsche Bank and Goldman Sachs. After the transaction settled on May 22, KNDS’s stake fell from 15.83% to roughly 10%, and the remaining holding is now subject to a 180-day lock-up.
The drop in potential selling pressure has given the stock room to breathe, but the technical picture remains cloudy. Since hitting a 52-week low of €43.99 in mid-May, the price has rebounded about 14%, yet it still sits 43% below the 52-week high of €88.73 reached early last October. More concerning for near-term bulls is the relative strength index, which at 78 flags the stock as overbought after a rapid recovery over just a few trading sessions. The share also continues to trade below both its short- and long-term moving averages — 2.99% and 15.42% below, respectively — underscoring that the uptrend has not yet been confirmed.
Fundamental data, meanwhile, offer a more encouraging narrative. First-quarter earnings per share jumped to €0.15 from €0.01 a year earlier, a sharp improvement off a low base, while revenue climbed roughly 4% to €283.6 million. Analysts are pencilling in full-year EPS of €1.73 for 2026, and the dividend is expected to rise to €0.723 per share from €0.58 previously. That earnings trajectory provides some justification for the recent buying, although the annualised monthly volatility of 42.88% serves as a reminder that Renk remains a high-beta name.
Should investors sell immediately? Or is it worth buying Renk?
The analyst community has largely stayed constructive. Jefferies reaffirmed a “Buy” rating on May 22, and DZ Bank and Warburg Research also renewed their purchase recommendations in May. Goldman Sachs adopted a neutral stance on May 14, without disclosing a specific price target.
The next major catalyst arrives on August 6, when Renk reports its second-quarter figures. Until then, the market must weigh whether the operational momentum can sustain the technical rally, or whether the overbought RSI forces a pause. The reduction of the KNDS overhang has undeniably improved the stock’s short-term outlook, but breaking through the moving averages will require more than just relief buying.
Ad
Renk Stock: Buy or Sell?! New Renk Analysis from May 25 delivers the answer:
The latest Renk figures speak for themselves: Urgent action needed for Renk investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 25.
Renk: Buy or sell? Read more here...
